Sumatriptan Nasal Spray — FDA Drug Shortage

No longer listed by FDA — Prasco Laboratories

The FDA lists a drug shortage record for Sumatriptan Nasal Spray (nasal spray) from Prasco Laboratories with status No longer listed by FDA. The shortage was first posted on Sep 8, 2025.

Shortage details

Status
No longer listed by FDA
Company
Prasco Laboratories
Package NDC
66993-081-69
Dosage Form
Nasal Spray
Presentation
Imitrex, Nasal Spray, 5 mg/100 uL (NDC 66993-081-69)
Initial Posting
Sep 8, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.